Nektar Therapeutics
NKTR
#4699
Rank
NZ$4.00 B
Marketcap
NZ$117.28
Share price
-1.84%
Change (1 day)
16.53%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2026 (TTM): -NZ$0.26 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are NZ$55.63 Million. In 2025 the company made an earning of -NZ$0.28 Billion a decrease over its 2024 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.26 Billion-4.38%
2025 -NZ$0.28 Billion30.44%
2024 -NZ$0.21 Billion-56.85%
2023 -NZ$0.49 Billion-24.31%
2022 -NZ$0.64 Billion-30.25%
2021 -NZ$0.92 Billion17.87%
2020 -NZ$0.78 Billion0.88%
2019 -NZ$0.77 Billion-164.46%
2018 NZ$1.19 B-810.61%
2017 -NZ$0.17 Billion-37.06%
2016 -NZ$0.27 Billion89.22%
2015 -NZ$0.15 Billion48.22%
2014 -NZ$95.13 Million-65.93%
2013 -NZ$0.28 Billion-6.81%
2012 -NZ$0.3 Billion28.95%
2011 -NZ$0.24 Billion258.8%
2010 -NZ$64.77 Million-63.94%
2009 -NZ$0.18 Billion-392.45%
2008 NZ$61.42 M-211.74%
2007 -NZ$54.98 Million-79.57%
2006 -NZ$0.27 Billion-16.9%
2005 -NZ$0.33 Billion81.53%
2004 -NZ$0.18 Billion54.19%
2003 -NZ$0.12 Billion-33.87%
2002 -NZ$0.18 Billion-9.6%
2001 -NZ$0.2 Billion73.39%
2000 -NZ$0.12 Billion108.9%
1999 -NZ$53.42 Million39.48%
1998 -NZ$38.3 Million60.02%
1997 -NZ$23.94 Million18.05%
1996 -NZ$20.28 Million31.82%
1995 -NZ$15.39 Million57.14%
1994 -NZ$9.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.40 B-17,168.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.51 B-7,058.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.88 B-6,070.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.89 Billion 233.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.98 B-8,740.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$25.62 B-9,734.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$9.25 M-103.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$0.41 B-255.84%๐Ÿ‡ฎ๐Ÿ‡ช Ireland